FDA raises concern over blood bank compliance

The Food and Drugs Authority (FDA) has expressed concern over persistent regulatory non-compliance in blood banking facilities, revealing that only 12 nationwide have met licensing standards despite years of audits and capacity-building.

Go to News Site